

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.44254782 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.44254782 |
| 3 | regulation of water loss via skin (GO:0033561) | 4.29483573 |
| 4 | keratinization (GO:0031424) | 4.17469337 |
| 5 | establishment of skin barrier (GO:0061436) | 4.02097314 |
| 6 | skin morphogenesis (GO:0043589) | 3.95489108 |
| 7 | protein localization to endosome (GO:0036010) | 3.54892915 |
| 8 | cell-substrate junction assembly (GO:0007044) | 3.48268715 |
| 9 | COPII vesicle coating (GO:0048208) | 3.45911073 |
| 10 | negative regulation of fatty acid transport (GO:2000192) | 3.35364926 |
| 11 | muscle filament sliding (GO:0030049) | 3.30325985 |
| 12 | actin-myosin filament sliding (GO:0033275) | 3.30325985 |
| 13 | cell adhesion mediated by integrin (GO:0033627) | 3.29209907 |
| 14 | vocalization behavior (GO:0071625) | 3.29013598 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.12756134 |
| 16 | synaptic vesicle maturation (GO:0016188) | 3.12035339 |
| 17 | epithelial cell-cell adhesion (GO:0090136) | 3.11283684 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07833666 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.07440452 |
| 20 | adherens junction assembly (GO:0034333) | 3.06715693 |
| 21 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.06017246 |
| 22 | skeletal muscle adaptation (GO:0043501) | 3.05001439 |
| 23 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.04402342 |
| 24 | actin-mediated cell contraction (GO:0070252) | 3.02477389 |
| 25 | focal adhesion assembly (GO:0048041) | 3.02340283 |
| 26 | cell-substrate adherens junction assembly (GO:0007045) | 3.02340283 |
| 27 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.01839890 |
| 28 | locomotory exploration behavior (GO:0035641) | 2.99002862 |
| 29 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.95921609 |
| 30 | wound healing, spreading of epidermal cells (GO:0035313) | 2.94069456 |
| 31 | vesicle coating (GO:0006901) | 2.93970926 |
| 32 | carnitine shuttle (GO:0006853) | 2.91132612 |
| 33 | multicellular organismal water homeostasis (GO:0050891) | 2.90523937 |
| 34 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.90021930 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 2.89602820 |
| 36 | proline transport (GO:0015824) | 2.89181792 |
| 37 | cell communication involved in cardiac conduction (GO:0086065) | 2.88699604 |
| 38 | cell communication by electrical coupling (GO:0010644) | 2.83623592 |
| 39 | actin filament-based movement (GO:0030048) | 2.82311657 |
| 40 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78137786 |
| 41 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.77683013 |
| 42 | sarcomere organization (GO:0045214) | 2.77515422 |
| 43 | chondrocyte development (GO:0002063) | 2.76384905 |
| 44 | activation of protein kinase A activity (GO:0034199) | 2.75677579 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.71739013 |
| 46 | glutamate secretion (GO:0014047) | 2.70774498 |
| 47 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.67551514 |
| 48 | regulation of cardioblast differentiation (GO:0051890) | 2.66766123 |
| 49 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65362101 |
| 50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.62584482 |
| 51 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.62457020 |
| 52 | glomerular basement membrane development (GO:0032836) | 2.62172312 |
| 53 | synaptic vesicle exocytosis (GO:0016079) | 2.62055234 |
| 54 | chemical homeostasis within a tissue (GO:0048875) | 2.61999688 |
| 55 | macroautophagy (GO:0016236) | 2.61933864 |
| 56 | skeletal muscle contraction (GO:0003009) | 2.60517352 |
| 57 | endoplasmic reticulum organization (GO:0007029) | 2.55863417 |
| 58 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.55118989 |
| 59 | myoblast fusion (GO:0007520) | 2.53917825 |
| 60 | detection of calcium ion (GO:0005513) | 2.53396821 |
| 61 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.53345146 |
| 62 | surfactant homeostasis (GO:0043129) | 2.51310513 |
| 63 | NADH metabolic process (GO:0006734) | 2.50461006 |
| 64 | desmosome organization (GO:0002934) | 2.50395941 |
| 65 | substrate-dependent cell migration (GO:0006929) | 2.49895349 |
| 66 | endocrine hormone secretion (GO:0060986) | 2.49840402 |
| 67 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.49744684 |
| 68 | neurotransmitter secretion (GO:0007269) | 2.49236418 |
| 69 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.48555598 |
| 70 | peptide cross-linking (GO:0018149) | 2.48067294 |
| 71 | cardiac conduction (GO:0061337) | 2.47194961 |
| 72 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.47109219 |
| 73 | keratinocyte differentiation (GO:0030216) | 2.46929457 |
| 74 | intestinal epithelial cell development (GO:0060576) | 2.46478067 |
| 75 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.44772530 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.41230661 |
| 77 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.41160731 |
| 78 | striated muscle atrophy (GO:0014891) | 2.41103996 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.41047363 |
| 80 | actomyosin structure organization (GO:0031032) | 2.40930189 |
| 81 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.40280392 |
| 82 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.39870335 |
| 83 | hippo signaling (GO:0035329) | 2.39328867 |
| 84 | membrane repolarization during action potential (GO:0086011) | 2.38539890 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.37425650 |
| 86 | lymph vessel development (GO:0001945) | 2.36969216 |
| 87 | protein localization to cell surface (GO:0034394) | 2.36654167 |
| 88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.36365402 |
| 89 | response to muscle activity (GO:0014850) | 2.35537900 |
| 90 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.35210556 |
| 91 | gap junction assembly (GO:0016264) | 2.34723701 |
| 92 | positive regulation of muscle hypertrophy (GO:0014742) | 2.34481392 |
| 93 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.34481392 |
| 94 | plasma membrane repair (GO:0001778) | 2.33668955 |
| 95 | sodium ion export (GO:0071436) | 2.32256752 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 2.32240257 |
| 97 | embryonic eye morphogenesis (GO:0048048) | 2.32143329 |
| 98 | regulation of synapse structural plasticity (GO:0051823) | 2.31954738 |
| 99 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.31577203 |
| 100 | water homeostasis (GO:0030104) | 2.31349785 |
| 101 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.29498279 |
| 102 | wound healing, spreading of cells (GO:0044319) | 2.28448463 |
| 103 | negative regulation of cell size (GO:0045792) | 2.28363523 |
| 104 | hypotonic response (GO:0006971) | 2.27955918 |
| 105 | dendrite morphogenesis (GO:0048813) | 2.27041307 |
| 106 | gamma-aminobutyric acid transport (GO:0015812) | 2.26502448 |
| 107 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.26015483 |
| 108 | myofibril assembly (GO:0030239) | 2.25005603 |
| 109 | peptidyl-proline hydroxylation (GO:0019511) | 2.24789581 |
| 110 | hemidesmosome assembly (GO:0031581) | 2.24458573 |
| 111 | basement membrane organization (GO:0071711) | 2.24380245 |
| 112 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23911835 |
| 113 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.22758599 |
| 114 | protein hydroxylation (GO:0018126) | 2.22038786 |
| 115 | ear development (GO:0043583) | 2.22032431 |
| 116 | relaxation of cardiac muscle (GO:0055119) | 2.21952771 |
| 117 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.21802927 |
| 118 | regulation of synaptic vesicle transport (GO:1902803) | 2.21247087 |
| 119 | cellular potassium ion homeostasis (GO:0030007) | 2.20417919 |
| 120 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.20303962 |
| 121 | linoleic acid metabolic process (GO:0043651) | 2.20276937 |
| 122 | carnitine transmembrane transport (GO:1902603) | 2.20205403 |
| 123 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.19311691 |
| 124 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.19239326 |
| 125 | keratinocyte proliferation (GO:0043616) | 2.19227853 |
| 126 | amyloid precursor protein metabolic process (GO:0042982) | 2.18802923 |
| 127 | maternal placenta development (GO:0001893) | 2.18631850 |
| 128 | membrane repolarization (GO:0086009) | 2.18492320 |
| 129 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18464530 |
| 130 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.18017365 |
| 131 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.17359145 |
| 132 | neuron recognition (GO:0008038) | 2.16720899 |
| 133 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.16673973 |
| 134 | biotin metabolic process (GO:0006768) | 2.16641114 |
| 135 | fatty acid transmembrane transport (GO:1902001) | 2.16382185 |
| 136 | regulation of membrane repolarization (GO:0060306) | 2.16225544 |
| 137 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.16196835 |
| 138 | negative regulation of vascular permeability (GO:0043116) | 2.15597473 |
| 139 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.15157602 |
| 140 | glycine transport (GO:0015816) | 2.14815017 |
| 141 | exploration behavior (GO:0035640) | 2.14451738 |
| 142 | axonal fasciculation (GO:0007413) | 2.14368627 |
| 143 | semaphorin-plexin signaling pathway (GO:0071526) | 2.14366157 |
| 144 | positive regulation of p38MAPK cascade (GO:1900745) | 2.14268114 |
| 145 | alanine transport (GO:0032328) | 2.14189511 |
| 146 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.13039281 |
| 147 | adherens junction organization (GO:0034332) | 2.12868866 |
| 148 | positive regulation of potassium ion transport (GO:0043268) | 2.12229921 |
| 149 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.11694681 |
| 150 | potassium ion import (GO:0010107) | 2.10591117 |
| 151 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.08407575 |
| 152 | cochlea development (GO:0090102) | 2.08350900 |
| 153 | protein localization to synapse (GO:0035418) | 2.07978119 |
| 154 | multicellular organismal signaling (GO:0035637) | 2.07973702 |
| 155 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.06534502 |
| 156 | innervation (GO:0060384) | 2.04546049 |
| 157 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.03917399 |
| 158 | potassium ion homeostasis (GO:0055075) | 2.03866656 |
| 159 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.03314187 |
| 160 | neuron cell-cell adhesion (GO:0007158) | 2.03288098 |
| 161 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.03182693 |
| 162 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.02756709 |
| 163 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.02165306 |
| 164 | protein targeting to Golgi (GO:0000042) | 2.01983466 |
| 165 | auditory behavior (GO:0031223) | 2.00954097 |
| 166 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.00709074 |
| 167 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.99311893 |
| 168 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 1.99295676 |
| 169 | membrane assembly (GO:0071709) | 1.99295672 |
| 170 | cardiac muscle cell action potential (GO:0086001) | 1.99248279 |
| 171 | axon extension (GO:0048675) | 1.98761803 |
| 172 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 1.97899329 |
| 173 | establishment of nucleus localization (GO:0040023) | 1.97641240 |
| 174 | neurotransmitter transport (GO:0006836) | 1.96629661 |
| 175 | regulation of axon guidance (GO:1902667) | 1.96538650 |
| 176 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.96291129 |
| 177 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 1.95421513 |
| 178 | dendritic spine morphogenesis (GO:0060997) | 1.94045351 |
| 179 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 1.93470391 |
| 180 | regulation of cardioblast proliferation (GO:0003264) | 1.93470391 |
| 181 | mating behavior (GO:0007617) | 1.93321108 |
| 182 | membrane depolarization during action potential (GO:0086010) | 1.92935963 |
| 183 | lymphangiogenesis (GO:0001946) | 1.92592764 |
| 184 | vesicle transport along microtubule (GO:0047496) | 1.92550110 |
| 185 | cellular response to vitamin D (GO:0071305) | 1.92266207 |
| 186 | regulation of potassium ion transmembrane transport (GO:1901379) | 1.91215633 |
| 187 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.91119552 |
| 188 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 1.89941964 |
| 189 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 1.89804093 |
| 190 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 1.89577858 |
| 191 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 1.89102044 |
| 192 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.88365867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.77278150 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.04471054 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.90193195 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69150080 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.56894655 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54224359 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53647461 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45467962 |
| 9 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40951188 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.31356150 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27784750 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24237062 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21709257 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21709257 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20245857 |
| 16 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.18906841 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18558028 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16720164 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14633289 |
| 20 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.11878530 |
| 21 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.11878530 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11796960 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09900505 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07181995 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02829288 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02086577 |
| 27 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96906413 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95344261 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95167092 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93134389 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87640433 |
| 32 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.86536730 |
| 33 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.86536730 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85141434 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79060153 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75942883 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.74982103 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74919979 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73348717 |
| 40 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.71817558 |
| 41 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68798537 |
| 42 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.67415624 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66582045 |
| 44 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65283663 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.64712518 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63627836 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62745940 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62318668 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.62287615 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60044372 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58995305 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58158568 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56922187 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56561992 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52192704 |
| 56 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49876577 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49505803 |
| 58 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.49061243 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.48811118 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48338137 |
| 61 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46079799 |
| 62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45072541 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44258858 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42779173 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42442534 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41421442 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40182376 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40066814 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38966972 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33422690 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32276359 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31005019 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30709941 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29177460 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28516949 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27994106 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27272725 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26628719 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26480137 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26468794 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25809868 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24623749 |
| 83 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24521034 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23874430 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23807489 |
| 86 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23523324 |
| 87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23387018 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22257886 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20884388 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20474316 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20270934 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20192800 |
| 93 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20064306 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18773176 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18682199 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18422702 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17787844 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17409050 |
| 99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16787364 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16617678 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15988844 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15988844 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15852131 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15825417 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14972553 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13732437 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13155471 |
| 108 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.12702477 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09915174 |
| 110 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09862785 |
| 111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09400531 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09358462 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09238826 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08582841 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07928962 |
| 116 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07345797 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07064255 |
| 118 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06882761 |
| 119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06595496 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06305235 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06267197 |
| 122 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06170374 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05740267 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05373130 |
| 125 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05370508 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05011799 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04729230 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03856545 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03684698 |
| 130 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02903214 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02251221 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02159298 |
| 133 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01642917 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01546868 |
| 135 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01035337 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00544618 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00165796 |
| 138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00082383 |
| 139 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98601286 |
| 140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98505262 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97942959 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97928749 |
| 143 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97906407 |
| 144 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97310109 |
| 145 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96581037 |
| 146 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96265382 |
| 147 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96149019 |
| 148 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96088692 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95917435 |
| 150 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95852983 |
| 151 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95598628 |
| 152 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94856682 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94474002 |
| 154 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94056318 |
| 155 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93906757 |
| 156 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93623581 |
| 157 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93489383 |
| 158 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92749009 |
| 159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92175923 |
| 160 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91928943 |
| 161 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91720592 |
| 162 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91173281 |
| 163 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90422277 |
| 164 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90143012 |
| 165 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.89065975 |
| 166 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.88682711 |
| 167 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88340249 |
| 168 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87680481 |
| 169 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87593917 |
| 170 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86266028 |
| 171 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86132366 |
| 172 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85437120 |
| 173 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.85216507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 3.68271388 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 2.72583805 |
| 3 | MP0004233_abnormal_muscle_weight | 2.70295523 |
| 4 | MP0003566_abnormal_cell_adhesion | 2.66032943 |
| 5 | MP0004272_abnormal_basement_membrane | 2.59963089 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.37173727 |
| 7 | MP0000013_abnormal_adipose_tissue | 2.29043129 |
| 8 | MP0005451_abnormal_body_composition | 2.24367331 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.09740450 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 1.99172778 |
| 11 | MP0000751_myopathy | 1.96785290 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 1.96679458 |
| 13 | MP0005409_darkened_coat_color | 1.95704409 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 1.94716838 |
| 15 | MP0005501_abnormal_skin_physiology | 1.92631307 |
| 16 | MP0005275_abnormal_skin_tensile | 1.91595398 |
| 17 | MP0002909_abnormal_adrenal_gland | 1.90696599 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.87785193 |
| 19 | MP0000733_abnormal_muscle_development | 1.85990064 |
| 20 | MP0003950_abnormal_plasma_membrane | 1.83282455 |
| 21 | MP0004270_analgesia | 1.81002689 |
| 22 | MP0000759_abnormal_skeletal_muscle | 1.80088536 |
| 23 | MP0002060_abnormal_skin_morphology | 1.77806120 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.74917570 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.70985257 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.70902443 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.60838775 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.60435461 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.60328539 |
| 30 | MP0003091_abnormal_cell_migration | 1.59336760 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.58640737 |
| 32 | MP0003122_maternal_imprinting | 1.58153616 |
| 33 | MP0005375_adipose_tissue_phenotype | 1.57707730 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.55361836 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.55105915 |
| 36 | MP0000467_abnormal_esophagus_morphology | 1.55049745 |
| 37 | MP0003880_abnormal_central_pattern | 1.54925544 |
| 38 | MP0000747_muscle_weakness | 1.54457941 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.53062725 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.52983420 |
| 41 | MP0006138_congestive_heart_failure | 1.52715099 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.51117044 |
| 43 | MP0009745_abnormal_behavioral_response | 1.48295255 |
| 44 | MP0009046_muscle_twitch | 1.47937118 |
| 45 | MP0003045_fibrosis | 1.47253603 |
| 46 | MP0005248_abnormal_Harderian_gland | 1.46563352 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.45111956 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.44826642 |
| 49 | MP0002896_abnormal_bone_mineralization | 1.44710855 |
| 50 | MP0004130_abnormal_muscle_cell | 1.43306687 |
| 51 | MP0005187_abnormal_penis_morphology | 1.41662384 |
| 52 | MP0005023_abnormal_wound_healing | 1.39045687 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.38048815 |
| 54 | MP0001216_abnormal_epidermal_layer | 1.36721914 |
| 55 | MP0004484_altered_response_of | 1.34829009 |
| 56 | MP0002269_muscular_atrophy | 1.33975809 |
| 57 | MP0003279_aneurysm | 1.32909459 |
| 58 | MP0002254_reproductive_system_inflammat | 1.32907946 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 1.31252028 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.28454017 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.28205476 |
| 62 | MP0002064_seizures | 1.27803653 |
| 63 | MP0001661_extended_life_span | 1.26985439 |
| 64 | MP0004858_abnormal_nervous_system | 1.26680254 |
| 65 | MP0010678_abnormal_skin_adnexa | 1.24125080 |
| 66 | MP0001968_abnormal_touch/_nociception | 1.23583902 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.23369535 |
| 68 | MP0002106_abnormal_muscle_physiology | 1.23171003 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.22369643 |
| 70 | MP0002108_abnormal_muscle_morphology | 1.21986569 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.21837920 |
| 72 | MP0004036_abnormal_muscle_relaxation | 1.21051654 |
| 73 | MP0004085_abnormal_heartbeat | 1.21029444 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 1.20068730 |
| 75 | MP0005670_abnormal_white_adipose | 1.19142243 |
| 76 | MP0001486_abnormal_startle_reflex | 1.18121579 |
| 77 | MP0002971_abnormal_brown_adipose | 1.17611313 |
| 78 | MP0005369_muscle_phenotype | 1.16979153 |
| 79 | MP0008004_abnormal_stomach_pH | 1.16961118 |
| 80 | MP0005620_abnormal_muscle_contractility | 1.16727625 |
| 81 | MP0003283_abnormal_digestive_organ | 1.14624391 |
| 82 | MP0001299_abnormal_eye_distance/ | 1.14320957 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.12544839 |
| 84 | MP0003868_abnormal_feces_composition | 1.10754588 |
| 85 | MP0008775_abnormal_heart_ventricle | 1.10263070 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.09633231 |
| 87 | MP0000377_abnormal_hair_follicle | 1.09477049 |
| 88 | MP0004885_abnormal_endolymph | 1.08981671 |
| 89 | MP0001346_abnormal_lacrimal_gland | 1.08135712 |
| 90 | MP0009840_abnormal_foam_cell | 1.08123071 |
| 91 | MP0000579_abnormal_nail_morphology | 1.07891290 |
| 92 | MP0002735_abnormal_chemical_nociception | 1.06189593 |
| 93 | MP0002272_abnormal_nervous_system | 1.06133270 |
| 94 | MP0000003_abnormal_adipose_tissue | 1.05604372 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 1.05533080 |
| 96 | MP0010386_abnormal_urinary_bladder | 1.04478461 |
| 97 | MP0002234_abnormal_pharynx_morphology | 1.04051659 |
| 98 | MP0002557_abnormal_social/conspecific_i | 1.04004982 |
| 99 | MP0001177_atelectasis | 1.03697139 |
| 100 | MP0000537_abnormal_urethra_morphology | 1.03008206 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 1.02432404 |
| 102 | MP0000627_abnormal_mammary_gland | 1.01523988 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 1.00668297 |
| 104 | MP0002733_abnormal_thermal_nociception | 0.99572027 |
| 105 | MP0010771_integument_phenotype | 0.98682006 |
| 106 | MP0002796_impaired_skin_barrier | 0.98343638 |
| 107 | MP0004043_abnormal_pH_regulation | 0.97999088 |
| 108 | MP0010630_abnormal_cardiac_muscle | 0.97920797 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.97221210 |
| 110 | MP0005330_cardiomyopathy | 0.97220273 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.97113380 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.96994472 |
| 113 | MP0003646_muscle_fatigue | 0.96694651 |
| 114 | MP0000462_abnormal_digestive_system | 0.96399314 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.93670657 |
| 116 | MP0000516_abnormal_urinary_system | 0.93670657 |
| 117 | MP0008569_lethality_at_weaning | 0.92882552 |
| 118 | MP0002184_abnormal_innervation | 0.92878675 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.90704577 |
| 120 | MP0003941_abnormal_skin_development | 0.90515243 |
| 121 | MP0001849_ear_inflammation | 0.90313037 |
| 122 | MP0002009_preneoplasia | 0.89815852 |
| 123 | MP0004510_myositis | 0.89292866 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.88012104 |
| 125 | MP0003828_pulmonary_edema | 0.87904090 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.87451092 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.86672326 |
| 128 | MP0002127_abnormal_cardiovascular_syste | 0.85990050 |
| 129 | MP0002736_abnormal_nociception_after | 0.85014923 |
| 130 | MP0001970_abnormal_pain_threshold | 0.84532814 |
| 131 | MP0000778_abnormal_nervous_system | 0.84517166 |
| 132 | MP0001958_emphysema | 0.84439082 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.83434093 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.83019565 |
| 135 | MP0000749_muscle_degeneration | 0.82788802 |
| 136 | MP0004087_abnormal_muscle_fiber | 0.82308141 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.81246706 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.80000703 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.79159302 |
| 140 | MP0001544_abnormal_cardiovascular_syste | 0.78440840 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.78440840 |
| 142 | MP0009053_abnormal_anal_canal | 0.77891827 |
| 143 | MP0003959_abnormal_lean_body | 0.77794859 |
| 144 | MP0003300_gastrointestinal_ulcer | 0.77689334 |
| 145 | MP0004924_abnormal_behavior | 0.77151476 |
| 146 | MP0005386_behavior/neurological_phenoty | 0.77151476 |
| 147 | MP0001881_abnormal_mammary_gland | 0.75041070 |
| 148 | MP0000383_abnormal_hair_follicle | 0.74858109 |
| 149 | MP0001243_abnormal_dermal_layer | 0.74558475 |
| 150 | MP0002822_catalepsy | 0.74104719 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.74088836 |
| 152 | MP0003195_calcinosis | 0.73083070 |
| 153 | MP0009250_abnormal_appendicular_skeleto | 0.72549374 |
| 154 | MP0004134_abnormal_chest_morphology | 0.72424814 |
| 155 | MP0002168_other_aberrant_phenotype | 0.72050349 |
| 156 | MP0001440_abnormal_grooming_behavior | 0.71558349 |
| 157 | MP0009931_abnormal_skin_appearance | 0.71257130 |
| 158 | MP0006054_spinal_hemorrhage | 0.71157987 |
| 159 | MP0010030_abnormal_orbit_morphology | 0.69074383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 4.44279109 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.40026220 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.31232540 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 3.35422309 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.33295883 |
| 6 | Distal lower limb muscle weakness (HP:0009053) | 3.30479269 |
| 7 | Focal motor seizures (HP:0011153) | 3.17591199 |
| 8 | Abnormality of nail color (HP:0100643) | 3.08745838 |
| 9 | Distal lower limb amyotrophy (HP:0008944) | 3.00240981 |
| 10 | Premature rupture of membranes (HP:0001788) | 2.82597551 |
| 11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.77602517 |
| 12 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.74525961 |
| 13 | Ventricular fibrillation (HP:0001663) | 2.68821857 |
| 14 | Action tremor (HP:0002345) | 2.65493166 |
| 15 | Arterial tortuosity (HP:0005116) | 2.60803059 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 2.60141606 |
| 17 | Prolonged QT interval (HP:0001657) | 2.59215884 |
| 18 | Sudden death (HP:0001699) | 2.57841415 |
| 19 | Focal seizures (HP:0007359) | 2.53958568 |
| 20 | Osteolytic defects of the hand bones (HP:0009699) | 2.50821497 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50821497 |
| 22 | Pheochromocytoma (HP:0002666) | 2.50497211 |
| 23 | Septate vagina (HP:0001153) | 2.48813303 |
| 24 | Round ear (HP:0100830) | 2.46744133 |
| 25 | Alopecia of scalp (HP:0002293) | 2.43108490 |
| 26 | Atrophic scars (HP:0001075) | 2.42636011 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 2.42207223 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 2.37501318 |
| 29 | Syncope (HP:0001279) | 2.36281871 |
| 30 | Atrial fibrillation (HP:0005110) | 2.30045931 |
| 31 | Broad metatarsal (HP:0001783) | 2.28106883 |
| 32 | Difficulty running (HP:0009046) | 2.27825529 |
| 33 | Vertebral compression fractures (HP:0002953) | 2.27580504 |
| 34 | Neck muscle weakness (HP:0000467) | 2.26985241 |
| 35 | Overgrowth (HP:0001548) | 2.26002292 |
| 36 | Hyporeflexia of lower limbs (HP:0002600) | 2.25007381 |
| 37 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.21394497 |
| 38 | Lower limb amyotrophy (HP:0007210) | 2.20789398 |
| 39 | Aortic dissection (HP:0002647) | 2.20645254 |
| 40 | Bundle branch block (HP:0011710) | 2.19357355 |
| 41 | Myopathic facies (HP:0002058) | 2.16507707 |
| 42 | Primary atrial arrhythmia (HP:0001692) | 2.15516666 |
| 43 | Atonic seizures (HP:0010819) | 2.15486589 |
| 44 | Hypoventilation (HP:0002791) | 2.14334204 |
| 45 | Epileptic encephalopathy (HP:0200134) | 2.14326403 |
| 46 | Agitation (HP:0000713) | 2.13931738 |
| 47 | Advanced eruption of teeth (HP:0006288) | 2.13594218 |
| 48 | Ulnar deviation of the wrist (HP:0003049) | 2.13175926 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.12652245 |
| 50 | Visual hallucinations (HP:0002367) | 2.11982246 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.10365698 |
| 52 | Lip pit (HP:0100267) | 2.07787086 |
| 53 | Mitral stenosis (HP:0001718) | 2.06339142 |
| 54 | Aplasia involving bones of the extremities (HP:0009825) | 2.06173163 |
| 55 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.06173163 |
| 56 | Aplasia of the phalanges of the hand (HP:0009802) | 2.06173163 |
| 57 | Distal arthrogryposis (HP:0005684) | 2.06014503 |
| 58 | Hypoplastic ischia (HP:0003175) | 2.04758740 |
| 59 | Bronchomalacia (HP:0002780) | 2.04055335 |
| 60 | Myoglobinuria (HP:0002913) | 2.02884920 |
| 61 | Hypercortisolism (HP:0001578) | 2.02632632 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.02484943 |
| 63 | Rhabdomyolysis (HP:0003201) | 2.01313409 |
| 64 | Abnormality of the ischium (HP:0003174) | 2.01061148 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00758602 |
| 66 | Broad face (HP:0000283) | 2.00517086 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.00268506 |
| 68 | Myokymia (HP:0002411) | 1.99799985 |
| 69 | Cervical subluxation (HP:0003308) | 1.98789575 |
| 70 | Calf muscle hypertrophy (HP:0008981) | 1.98701811 |
| 71 | Ventricular arrhythmia (HP:0004308) | 1.96883528 |
| 72 | Sparse lateral eyebrow (HP:0005338) | 1.96419387 |
| 73 | Asymmetry of the thorax (HP:0001555) | 1.95642398 |
| 74 | Supraventricular arrhythmia (HP:0005115) | 1.95095978 |
| 75 | Absent frontal sinuses (HP:0002688) | 1.94746511 |
| 76 | Progressive cerebellar ataxia (HP:0002073) | 1.94608780 |
| 77 | Absence seizures (HP:0002121) | 1.93490719 |
| 78 | Ketoacidosis (HP:0001993) | 1.93228089 |
| 79 | Bradycardia (HP:0001662) | 1.93080184 |
| 80 | Neuroendocrine neoplasm (HP:0100634) | 1.92895791 |
| 81 | Short nail (HP:0001799) | 1.92493579 |
| 82 | Hyperglycemia (HP:0003074) | 1.92453756 |
| 83 | Supraventricular tachycardia (HP:0004755) | 1.91967310 |
| 84 | Abnormal EKG (HP:0003115) | 1.91583157 |
| 85 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90756922 |
| 86 | Febrile seizures (HP:0002373) | 1.90637129 |
| 87 | Germ cell neoplasia (HP:0100728) | 1.90316200 |
| 88 | Abnormality of the calf musculature (HP:0001430) | 1.90117633 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89821009 |
| 90 | Ventricular tachycardia (HP:0004756) | 1.89137703 |
| 91 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.87837367 |
| 92 | Subaortic stenosis (HP:0001682) | 1.87837367 |
| 93 | Wormian bones (HP:0002645) | 1.85867377 |
| 94 | Mitral valve prolapse (HP:0001634) | 1.84932339 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 1.81933679 |
| 96 | Hypotrichosis (HP:0001006) | 1.80822114 |
| 97 | Shallow orbits (HP:0000586) | 1.79738798 |
| 98 | Difficulty climbing stairs (HP:0003551) | 1.79319554 |
| 99 | Thick nail (HP:0001805) | 1.77805733 |
| 100 | Back pain (HP:0003418) | 1.77797433 |
| 101 | Anxiety (HP:0000739) | 1.76865750 |
| 102 | Onycholysis (HP:0001806) | 1.76047081 |
| 103 | Esophageal varix (HP:0002040) | 1.75929126 |
| 104 | Plantar hyperkeratosis (HP:0007556) | 1.74830905 |
| 105 | Bulbar palsy (HP:0001283) | 1.74576085 |
| 106 | Acanthosis nigricans (HP:0000956) | 1.73424839 |
| 107 | Thin bony cortex (HP:0002753) | 1.73292740 |
| 108 | Aortic aneurysm (HP:0004942) | 1.73162772 |
| 109 | Cardiovascular calcification (HP:0011915) | 1.72303390 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72207040 |
| 111 | Buphthalmos (HP:0000557) | 1.72164301 |
| 112 | Nail dystrophy (HP:0008404) | 1.71873412 |
| 113 | Termporal pattern (HP:0011008) | 1.71809416 |
| 114 | Insidious onset (HP:0003587) | 1.71809416 |
| 115 | Megalencephaly (HP:0001355) | 1.71567137 |
| 116 | Hyperventilation (HP:0002883) | 1.71103411 |
| 117 | Natal tooth (HP:0000695) | 1.70341695 |
| 118 | Popliteal pterygium (HP:0009756) | 1.69874584 |
| 119 | Hyperkalemia (HP:0002153) | 1.69630889 |
| 120 | Neonatal short-limb short stature (HP:0008921) | 1.69529406 |
| 121 | Symptomatic seizures (HP:0011145) | 1.69312929 |
| 122 | Growth hormone excess (HP:0000845) | 1.69181719 |
| 123 | Absent eyelashes (HP:0000561) | 1.68254911 |
| 124 | Ulnar bowing (HP:0003031) | 1.68078036 |
| 125 | Oligomenorrhea (HP:0000876) | 1.67812002 |
| 126 | Cerebral aneurysm (HP:0004944) | 1.67674069 |
| 127 | Spinal cord compression (HP:0002176) | 1.67500835 |
| 128 | EMG: neuropathic changes (HP:0003445) | 1.67388778 |
| 129 | Palmoplantar hyperkeratosis (HP:0000972) | 1.67387798 |
| 130 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.66979245 |
| 131 | Milia (HP:0001056) | 1.66720622 |
| 132 | Depression (HP:0000716) | 1.66339445 |
| 133 | Impaired social interactions (HP:0000735) | 1.65586744 |
| 134 | Abnormal social behavior (HP:0012433) | 1.65586744 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.64889425 |
| 136 | Spinal rigidity (HP:0003306) | 1.64307349 |
| 137 | Torticollis (HP:0000473) | 1.64099811 |
| 138 | Dysmetric saccades (HP:0000641) | 1.64092246 |
| 139 | Type 1 muscle fiber predominance (HP:0003803) | 1.63121407 |
| 140 | Ankle clonus (HP:0011448) | 1.62492889 |
| 141 | Hypoplasia of the iris (HP:0007676) | 1.61910222 |
| 142 | Hyperparathyroidism (HP:0000843) | 1.61886483 |
| 143 | Subacute progressive viral hepatitis (HP:0006572) | 1.61762015 |
| 144 | Fragile skin (HP:0001030) | 1.61726471 |
| 145 | Areflexia of lower limbs (HP:0002522) | 1.61379141 |
| 146 | Failure to thrive in infancy (HP:0001531) | 1.60879491 |
| 147 | Hepatoblastoma (HP:0002884) | 1.60525968 |
| 148 | Vascular tortuosity (HP:0004948) | 1.60102369 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.59974672 |
| 150 | Hamartoma of the eye (HP:0010568) | 1.59967434 |
| 151 | Postural tremor (HP:0002174) | 1.59839983 |
| 152 | Micronodular cirrhosis (HP:0001413) | 1.59529172 |
| 153 | Knee flexion contracture (HP:0006380) | 1.58769191 |
| 154 | Protrusio acetabuli (HP:0003179) | 1.56430956 |
| 155 | Truncal ataxia (HP:0002078) | 1.55902950 |
| 156 | Exotropia (HP:0000577) | 1.55260484 |
| 157 | Potter facies (HP:0002009) | 1.54995168 |
| 158 | Facial shape deformation (HP:0011334) | 1.54995168 |
| 159 | Abnormal eating behavior (HP:0100738) | 1.54869532 |
| 160 | Lymphangioma (HP:0100764) | 1.54551562 |
| 161 | Broad-based gait (HP:0002136) | 1.52735369 |
| 162 | Epileptiform EEG discharges (HP:0011182) | 1.52726834 |
| 163 | Macroorchidism (HP:0000053) | 1.52605497 |
| 164 | EEG with generalized epileptiform discharges (HP:0011198) | 1.52377989 |
| 165 | Ulnar claw (HP:0001178) | 1.51591364 |
| 166 | Abnormal atrioventricular conduction (HP:0005150) | 1.50968859 |
| 167 | Scapular winging (HP:0003691) | 1.50271174 |
| 168 | Adrenal overactivity (HP:0002717) | 1.49665387 |
| 169 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.49353970 |
| 170 | Enlarged epiphyses (HP:0010580) | 1.48898402 |
| 171 | Hypsarrhythmia (HP:0002521) | 1.48539514 |
| 172 | Increased connective tissue (HP:0009025) | 1.48485048 |
| 173 | Poor eye contact (HP:0000817) | 1.48154970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.04052627 |
| 2 | NTRK3 | 2.98324199 |
| 3 | LATS1 | 2.45997952 |
| 4 | EEF2K | 2.41416538 |
| 5 | TIE1 | 2.41273635 |
| 6 | PKN2 | 2.26971474 |
| 7 | FER | 2.17639174 |
| 8 | MST1R | 2.15465677 |
| 9 | FRK | 2.12916423 |
| 10 | MAP3K4 | 1.94795067 |
| 11 | LMTK2 | 1.93598201 |
| 12 | INSRR | 1.90680129 |
| 13 | CASK | 1.89072685 |
| 14 | TESK1 | 1.87274969 |
| 15 | MAP3K2 | 1.86563443 |
| 16 | PRKD3 | 1.84586257 |
| 17 | MAP3K9 | 1.82861429 |
| 18 | EPHA4 | 1.82777074 |
| 19 | MARK1 | 1.76126280 |
| 20 | RIPK1 | 1.71937155 |
| 21 | EPHB2 | 1.69863130 |
| 22 | TRPM7 | 1.64214836 |
| 23 | MET | 1.57116519 |
| 24 | CDK12 | 1.51827396 |
| 25 | MUSK | 1.51540689 |
| 26 | IRAK3 | 1.48837948 |
| 27 | MAP3K3 | 1.47360282 |
| 28 | MINK1 | 1.46973502 |
| 29 | AKT3 | 1.45236433 |
| 30 | NTRK1 | 1.43783189 |
| 31 | PAK3 | 1.39911027 |
| 32 | DDR2 | 1.37619203 |
| 33 | MAP2K7 | 1.35379938 |
| 34 | LATS2 | 1.35361803 |
| 35 | MAP2K4 | 1.35344314 |
| 36 | ICK | 1.35280201 |
| 37 | PHKG1 | 1.30933677 |
| 38 | PHKG2 | 1.30933677 |
| 39 | MAPKAPK3 | 1.24153689 |
| 40 | TRIB3 | 1.23016520 |
| 41 | NTRK2 | 1.22323458 |
| 42 | EPHB1 | 1.21577750 |
| 43 | MTOR | 1.21410978 |
| 44 | RET | 1.19285137 |
| 45 | PTK6 | 1.16767641 |
| 46 | SIK1 | 1.16706972 |
| 47 | MYLK | 1.15963580 |
| 48 | PDGFRA | 1.13964010 |
| 49 | PAK4 | 1.13606939 |
| 50 | CAMKK2 | 1.11968302 |
| 51 | SGK2 | 1.10816533 |
| 52 | DAPK2 | 1.09584395 |
| 53 | EPHA3 | 1.09520433 |
| 54 | CAMKK1 | 1.09487073 |
| 55 | PAK6 | 1.07853298 |
| 56 | CDC42BPA | 1.07586240 |
| 57 | WNK4 | 1.06539824 |
| 58 | PRKCH | 1.05902764 |
| 59 | ILK | 1.04859589 |
| 60 | OBSCN | 1.04280635 |
| 61 | PTK2 | 1.03504770 |
| 62 | PIK3CA | 1.02208360 |
| 63 | DMPK | 1.01298875 |
| 64 | SMG1 | 0.98980171 |
| 65 | CDK5 | 0.98495795 |
| 66 | SGK223 | 0.98043038 |
| 67 | SGK494 | 0.98043038 |
| 68 | FGFR2 | 0.96784352 |
| 69 | PLK2 | 0.94826263 |
| 70 | SGK3 | 0.94720826 |
| 71 | KSR2 | 0.94368165 |
| 72 | PRKCE | 0.94095483 |
| 73 | ERN1 | 0.93784461 |
| 74 | TGFBR2 | 0.93066627 |
| 75 | FGFR4 | 0.88746788 |
| 76 | BCR | 0.87941586 |
| 77 | STK38 | 0.87168931 |
| 78 | LIMK1 | 0.85734479 |
| 79 | CAMK1G | 0.85157724 |
| 80 | ERBB3 | 0.84013582 |
| 81 | PTK2B | 0.83867896 |
| 82 | MAP3K12 | 0.83577248 |
| 83 | PDK3 | 0.83393765 |
| 84 | PDK4 | 0.83393765 |
| 85 | ROCK1 | 0.83220250 |
| 86 | STK38L | 0.82299037 |
| 87 | PRPF4B | 0.81544671 |
| 88 | MAP2K1 | 0.79447002 |
| 89 | SIK3 | 0.78987821 |
| 90 | PIK3CG | 0.77965976 |
| 91 | RPS6KB2 | 0.77963074 |
| 92 | CAMK2A | 0.77572525 |
| 93 | FGFR3 | 0.75721843 |
| 94 | NEK9 | 0.75536252 |
| 95 | STK24 | 0.75510516 |
| 96 | KSR1 | 0.74826687 |
| 97 | ARAF | 0.74142343 |
| 98 | PRKD2 | 0.73322577 |
| 99 | PDK2 | 0.72121236 |
| 100 | LRRK2 | 0.71818638 |
| 101 | WNK1 | 0.70884696 |
| 102 | MAP3K6 | 0.70244234 |
| 103 | PRKAA2 | 0.68618822 |
| 104 | MAP3K7 | 0.68597865 |
| 105 | PRKD1 | 0.67361914 |
| 106 | PRKCG | 0.66660689 |
| 107 | PAK2 | 0.65541359 |
| 108 | WNK3 | 0.65469943 |
| 109 | GRK5 | 0.65396010 |
| 110 | TTN | 0.65085627 |
| 111 | MAPK12 | 0.63205099 |
| 112 | MAP3K1 | 0.62700724 |
| 113 | NEK6 | 0.62631970 |
| 114 | FGFR1 | 0.61780414 |
| 115 | STK11 | 0.59087443 |
| 116 | MOS | 0.58930207 |
| 117 | STK39 | 0.58398871 |
| 118 | CAMK2D | 0.57594398 |
| 119 | SGK1 | 0.57524346 |
| 120 | MAPK13 | 0.57358556 |
| 121 | MAP2K3 | 0.56312917 |
| 122 | OXSR1 | 0.54777434 |
| 123 | CSNK1G2 | 0.53584874 |
| 124 | RPS6KB1 | 0.53538867 |
| 125 | UHMK1 | 0.53145813 |
| 126 | SCYL2 | 0.52897825 |
| 127 | MARK2 | 0.51613223 |
| 128 | AKT2 | 0.51085503 |
| 129 | RPS6KA2 | 0.50917293 |
| 130 | CAMK1D | 0.50172255 |
| 131 | NUAK1 | 0.48776649 |
| 132 | CAMK1 | 0.48472021 |
| 133 | CAMK2B | 0.48376507 |
| 134 | ERBB4 | 0.48168271 |
| 135 | PDPK1 | 0.45964225 |
| 136 | TNIK | 0.44003914 |
| 137 | CHUK | 0.41868987 |
| 138 | PRKAA1 | 0.41509266 |
| 139 | CAMK2G | 0.40336127 |
| 140 | PDGFRB | 0.40176110 |
| 141 | ROCK2 | 0.39211073 |
| 142 | CAMK4 | 0.38733668 |
| 143 | EIF2AK1 | 0.37783527 |
| 144 | TAOK1 | 0.37023022 |
| 145 | PDK1 | 0.36893116 |
| 146 | GSK3A | 0.35617599 |
| 147 | CDK6 | 0.34643435 |
| 148 | JAK1 | 0.33655819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Insulin secretion_Homo sapiens_hsa04911 | 1.85892297 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80145931 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78853403 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.73372593 |
| 5 | Thyroid cancer_Homo sapiens_hsa05216 | 1.71133544 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.69735496 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67318636 |
| 8 | Renin secretion_Homo sapiens_hsa04924 | 1.56470973 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.55841368 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53643147 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.53521433 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.52849578 |
| 13 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.52138466 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51542973 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.50630323 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50045882 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.47506453 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47095929 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46597608 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43384701 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42732206 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41637922 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40477660 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39789464 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39419691 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36568290 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32701660 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31811544 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31190772 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.29728228 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29214221 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27809511 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27258720 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.26928944 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26332812 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.25508725 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.23194790 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22571831 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22486797 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21521499 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21244488 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17627664 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.17172074 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15595911 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14463965 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13662582 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11172865 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10810543 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09463327 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09323271 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07844544 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04373829 |
| 53 | Prostate cancer_Homo sapiens_hsa05215 | 1.04292908 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02900377 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 1.02551341 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.00845013 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00764663 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 1.00469048 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99839058 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99011637 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.98533188 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98463444 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97719909 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.97550118 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97081015 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96594700 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96407170 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95407047 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95292562 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95161788 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92735248 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92065784 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90284500 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88986927 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88679593 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.88546878 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88336470 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88181381 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88003095 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86892515 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86291779 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86031020 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84095458 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83135099 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82636080 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.82328903 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.82276149 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80632395 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.80365067 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79487601 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77778704 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75782195 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75587142 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74529138 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.73593240 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73563209 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72094602 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70994797 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69768535 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69473252 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68712831 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66583721 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.65926420 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65732708 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65307732 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65307700 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65236902 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65217043 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64621328 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64541040 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64176581 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64116424 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63696252 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63612463 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63565517 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62561091 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.61552403 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.61457769 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61207529 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61153134 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60379474 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60326062 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60033614 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58746483 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58140208 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.57856955 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.57524162 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.57364251 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56820525 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56264175 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54728163 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54546269 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54517615 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53571421 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53264544 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52429758 |
| 137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51665100 |
| 138 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51650996 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51583226 |
| 140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50610648 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.50573899 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50514658 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50468333 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49854002 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49831333 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49484782 |

